Evaluation of the Diagnostic Accuracy of Different Imaging Modalities in Patients with Pathologic Nipple Discharge

Background/Objectives: To evaluate the diagnostic accuracy of different imaging modalities in patients with pathologic nipple discharge.

Methods

This is a single-centre retrospective analysis of patients with pathologic nipple discharge. All performed imaging modalities were reviewed for their sensitivity and specificity in correctly diagnosing malignancy, as well as lesions with uncertain malignant potential (B3).

Results

Of 388 patients, pathology or follow-up confirmed 41 cases of malignancy (15 breast cancer, 26 ductal carcinoma in situ (DCIS)), 151 cases of B3 lesions, and 196 benign cases. The combination of ultrasound and mammography/tomosynthesis achieved a sensitivity of 82.5% (95% CI 68.1–91.3) and a specificity of 83.5% (77.4–88.2) for the detection of malignancy. For the classification of B3 lesions as suspicious (BI-RADS 4/5), the sensitivity and specificity were 33.8% (26.7–41.7) and 83.5% (77.4–88.2), respectively. Ductography demonstrated a sensitivity of 89.3% (72.8–96.3) and a specificity of 13.3% (8.2–20.8) for malignancy, while MRI showed a sensitivity of 71.4% (45.4–88.3) and a specificity of 90.0% (76.9–96.0). In classifying B3 lesions as suspicious, ductography reached a sensitivity of 94.8% (89.7–97.5) and a specificity of 13.3% (8.2–20.8), compared to 75.9% (57.9–87.8) and 90.0% (76.9–96.0), respectively, for MRI.